UK Markets closed

Guardant Health, Inc. (GH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
106.52+0.08 (+0.08%)
As of 12:23PM EDT. Market open.
Currency in USD

Valuation measures

Market cap (intra-day) 5N/A
Enterprise value 3N/A
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 7N/A

Trading information

Stock price history

Beta (5Y monthly) 0.49
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3181.07
52-week low 396.66
50-day moving average 3119.03
200-day moving average 3124.20

Share statistics

Avg vol (3-month) 3909.66k
Avg vol (10-day) 31M
Shares outstanding 5101.12M
Implied shares outstanding 6N/A
Float 896.34M
% held by insiders 14.40%
% held by institutions 191.35%
Shares short (29 Jul 2021) 43.28M
Short ratio (29 Jul 2021) 44.31
Short % of float (29 Jul 2021) 43.38%
Short % of shares outstanding (29 Jul 2021) 43.23%
Shares short (prior month 29 Jun 2021) 43.93M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021


Profit margin -116.99%
Operating margin (ttm)-111.61%

Management effectiveness

Return on assets (ttm)-12.65%
Return on equity (ttm)-36.74%

Income statement

Revenue (ttm)323.65M
Revenue per share (ttm)3.22
Quarterly revenue growth (yoy)38.80%
Gross profit (ttm)194.19M
EBITDA -341.62M
Net income avi to common (ttm)-378.65M
Diluted EPS (ttm)-3.39
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.79B
Total cash per share (mrq)17.69
Total debt (mrq)1.35B
Total debt/equity (mrq)159.64
Current ratio (mrq)19.57
Book value per share (mrq)8.38

Cash flow statement

Operating cash flow (ttm)-146.16M
Levered free cash flow (ttm)-47.39M